ORLYNVAH™ (pronounced Or-lin-va) is the first FDA-approved oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women with limited or no alternative oral antibacterial treatment options.

For more information or inquiries relating to ORLYNVAH™, visit www.Orlynvah.com